AbbVie's hepatitis C treatment helps 96 pct of patients in trial
(Reuters) - AbbVie Inc said a late-stage trial of its experimental oral hepatitis C treatment showed about 96 percent of patients had no detectable le...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/1SFSJEA-Cyo/story01.htm
No comments:
Post a Comment